Log In
Print
BCIQ
Print
Print this Print this
 

OPN-305

  Manage Alerts
Collapse Summary General Information
Company Opsona Therapeutics Ltd.
DescriptionHumanized IgG4 mAb against the toll-like receptor 2 (TLR2)
Molecular Target Toll-like receptor 2 (TLR2)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today